Abstract
The use of cannabis for medicinal purposes has increased globally over the past decade since patient access to medicinal cannabis has been legislated across jurisdictions in Europe, the United Kingdom, the United States, Canada, and Australia. Yet, evidence relating to the effect of medical cannabis on the management of symptoms for a suite of conditions is only just emerging. Although there is considerable engagement from many stakeholders to add to the evidence base through randomized controlled trials, many gaps in the literature remain. Data from real-world and patient reported sources can provide opportunities to address this evidence deficit. This real-world data can be captured from a variety of sources such as found in routinely collected health care and health services records that include but are not limited to patient generated data from medical, administrative and claims data, patient reported data from surveys, wearable trackers, patient registries, and social media. In this systematic scoping review, we seek to understand the utility of online user generated text into the use of cannabis as a medicine. In this scoping review, we aimed to systematically search published literature to examine the extent, range, and nature of research that utilises user-generated content to examine to cannabis as a medicine. The objective of this methodological review is to synthesise primary research that uses social media discourse and internet search engine queries to answer the following questions: (i) In what way, is online user-generated text used as a data source in the investigation of cannabis as a medicine? (ii) What are the aims, data sources, methods, and research themes of studies using online user-generated text to discuss the medicinal use of cannabis. We conducted a manual search of primary research studies which used online user-generated text as a data source using the MEDLINE, Embase, Web of Science, and Scopus databases in October 2022. Editorials, letters, commentaries, surveys, protocols, and book chapters were excluded from the review. Forty-two studies were included in this review, twenty-two studies used manually labelled data, four studies used existing meta-data (Google trends/geo-location data), two studies used data that was manually coded using crowdsourcing services, and two used automated coding supplied by a social media analytics company, fifteen used computational methods for annotating data. Our review reflects a growing interest in the use of user-generated content for public health surveillance. It also demonstrates the need for the development of a systematic approach for evaluating the quality of social media studies and highlights the utility of automatic processing and computational methods (machine learning technologies) for large social media datasets. This systematic scoping review has shown that user-generated content as a data source for studying cannabis as a medicine provides another means to understand how cannabis is perceived and used in the community. As such, it provides another potential ‘tool’ with which to engage in pharmacovigilance of, not only cannabis as a medicine, but also other novel therapeutics as they enter the market.
Introduction
Genetic analysis of ancients cannabis indicates the plant cannabis sativa was first cultivated for use as a as a medicinal agent up to 2400 years ago [1]. From the 1800’s, people in the United States (US), widely used cannabis as a medicine by either prescription or as an over the counter therapeutic [2]. Yet by the mid-20th century, cannabis use was prohibited in many parts of the developed world with the passing of legislation in the US, the United Kingdom (UK) and various European countries that proscribed its use [3–6]. Since the 2000s, the use of cannabis for medicinal purposes has been decriminalized in many countries including Israel, Canada, Netherlands, United States, United Kingdom, and Australia [7–9]. More recently, new evidence regarding the clinical effect of medical cannabis on the management of symptoms for some conditions [10] has triggered public interest in cannabis and cannabis-derived products [11,12], resulting in a global trend towards public acceptance, and subsequent legalisation of cannabis for both medicinal and non-medicinal use.
There is emerging evidence of cannabis efficacy for childhood epilepsy, spasticity, and neuropathic pain in multiple sclerosis, acquired immunodeficiency syndrome (AIDS) wasting syndrome, and cancer chemotherapy-induced nausea and vomiting [13–15]. Although researchers are investigating cannabis for treating cancer, psychiatric disorders [16], sleep disorders [17], chronic pain [18] and inflammatory conditions such as rheumatoid arthritis [19], there is currently insufficient evidence to support its clinical use. Scientific studies on emerging therapeutics typically exclude vulnerable populations such as pregnant women, young people, the elderly, patients with multimorbidity and polypharmacy, and this limits the availability of evidence for cannabis effectiveness across these population groups [20].
Cannabis as medicine is associated with a rapidly expanding industry [21]. Patient demand is increasing, as is reflected in an increasing number of approvals for prescriptions over time [22], with one study showing that 61% of Australian GPs surveyed reported one or more patient enquiries regarding medical cannabis [23]. With this increasing demand, is sophisticated marketing by medicinal cannabis companies that leverages evidence from a small number of studies to promote their products [24,25]. In light of this, concerns regarding patient safety is warranted especially when marketing for some cannabinoid products is associated with inadequate labelling and/or inappropriate dosage recommendations [26]. These concerns are compounded by the downscheduling of over-the-counter cannabis products which do not require a prescription [27] and the illicit drug market [28]. Given this dynamic interplay between marketing, product innovation, regulation, and consumer demand, innovative methods are required to augment existing established approaches to the surveillance and monitoring of emerging and unapproved drugs.
Although there is considerable engagement from many stakeholders to improve the scientific evidence regarding the efficacy and safety of cannabis through randomised controlled trials, many gaps remain in the literature [29]. Yet data from real-world and patient reported data sources could provide opportunities to address this evidence deficit [30]. This real-world data can be captured from a variety of sources such as found in routinely collected health care and health services records that include but are not limited to patient generated data from medical, administrative and claims data, as well as patient reported data from surveys, wearable trackers, patient registries, and social media [31–33].
People readily consult the internet when looking for and sharing health information [34,35]. According to 2017 survey of Health Information National Trends, almost 78% of US adults used online searches first to inquire about health or medical information [34]. Data resulting from these online activities is labelled ‘user generated’ and is increasingly becoming a component of surveillance systems in the health data domain [36]. Monitoring user-generated data on the web can be a timely and inexpensive way to generated population-level insights [37]. The collective experiences and opinions shared online are an easily accessible wide-ranging data source for tracking emerging trends–which might be unavailable or less noticeable by other surveillance systems.
The objective of this systematic scoping review is to understand the utility of online user generated text in providing insight into the use of cannabis as a medicine. In this review, we aim to systematically search published literature to examine the extent, range, and nature of research that utilises user-generated content to examine cannabis as a medicine [38–40]. The objective of this review is to synthesise primary research that uses social media discourse and internet search engine queries to answer the following questions:
In what way, is online user-generated text used as a data source in the investigation of cannabis as a medicine?
What are the aims, data sources, methods, and research themes of studies using online user-generated text to discuss the medicinal use of cannabis?
Materials and methods
Search strategy
For this review, we used an established methodological framework for scoping reviews to inform our methodology and we reported the review in accordance with the PRISMA reporting guidelines [38–41]. Literature database queries were developed for four categories of studies. The first three categories used social media text as a data source, the fourth relied on internet search engine query data. For the first category, the database queries combined words used to describe social media forums, and cannabis-related keywords and general medical-related keywords (Table 1 Category 1). The second category also included the social media and cannabis-related keywords, but used keywords specific to psychiatric disorders, for which the use of medical cannabis has been described. Our search terms for this second category were informed by a systematic review of medicinal cannabis for psychiatric disorders [16] (Table 1 Category 2). The third category included social media and cannabis related keywords but focused on non-psychiatric medical conditions for which cannabis is sometimes used (Table 1 Category 3). The fourth category included studies using Internet search engine queries as a data source, there were no medical conditions included in these searches (Table 1 Category 4). A manual search of MEDLINE: Web of Science (1900–2022), Embase: OVID (1974–2022), Web of Science: Core Collection (1900–2022), and Scopus (1996–2022) databases was conducted by SKH and CMH in May 2021 and again in October 2022. The search was limited to English-language studies that were published between January 1974 and April 2022 (S1 Appendix).
Table 1. Search strategy.
| CATEGORY 1—SOCIAL MEDIA, CANNABIS, AND MEDICAL TERMS AS KEYWORDS | ||
| Social media related Keywords | Cannabis keywords | Medical keywords |
| ‘Social media’ OR twitter OR reddit OR instagram OR youtube OR pinterest OR facebook OR ‘social network forum’ OR ‘Online health community’ OR ‘message board’ | cannabis OR cannabis OR cannabinoids OR delta-9-tetrahydrocannabinol OR cannabidiol OR cbd OR cbg OR cbn OR thc OR weed | medical OR medicinal OR patient OR patients OR medicine OR doctor OR position OR care OR therapy OR therapeutic |
| CATEGORY 2—SOCIAL MEDIA, CANNABIS, AND PSYCHIATRIC DISORDERS KEYWORDS | ||
| Social media related Keywords | Cannabis keywords | Psychiatric disorders |
| ‘Social media’ OR twitter OR reddit OR instagram OR youtube OR pinterest OR facebook OR ‘social network forum’ OR ‘Online health community’ OR ‘message board’ | cannabis OR cannabis OR cannabinoids OR delta-9-tetrahydrocannabinol OR cannabidiol OR cbd OR cbg OR cbn OR thc OR weed | depression OR depressive OR ‘mental illness*’ OR ‘mental disorder*’ OR ‘mental health’ OR ‘mood disorder*’ OR ‘affective disorder*’ OR anxi* OR ‘panic disorder’ OR ‘obsessive compulsive’ OR adhd OR ‘attention deficit’ OR phobi* OR bipolar OR psychiat* OR psychological OR psychosis OR psychotic OR schizophr* OR ‘severe mental*’ OR ‘serious mental*’ OR antidepress* OR antipsychotic* OR ‘post traumatic*’ OR ‘personality disorder*’ OR stress |
| CATEGORY 3—SOCIAL MEDIA, CANNABIS AND VARIOUS MEDICAL (NON-PSYCHIATRIC) CONDITIONS/ ILLNESSES KEYWORDS | ||
| Social media related Keywords | Cannabis keywords | Medical conditions |
| ‘Social media’ OR twitter OR reddit OR instagram OR youtube OR pinterest OR facebook OR ‘social network forum’ OR ‘Online health community’ OR ‘message board’ | cannabis OR cannabis OR cannabinoids OR delta-9-tetrahydrocannabinol OR cannabidiol OR cbd OR cbg OR cbn OR thc OR weed | Pain, Opioid, Alzheimer, sleep, OR insomnia, inflammatory, arthritis, Multiple Sclerosis, Endometriosis |
| CATEGORY 4—SEARCH ENGINE QUERIES AND CANNABIS KEYWORDS | ||
| Search Engine keywords | Cannabis keywords | |
| ‘Search engine’ OR ‘search log’ OR ‘search queries’ OR ‘online search’ OR ‘internet Search’ OR ‘web search’ | cannabis OR Cannabis OR Cannabinoids OR Delta-9-Tetrahydrocannabinol OR Cannabidiol OR CBD OR CBG OR CBN OR THC OR weed | |
The inclusion criteria for this review were: (i) peer reviewed research studies, (ii) peer reviewed conference papers (iii) studies which used online user-generated text as a data source, and (iv) social media research that was either directly focused on cannabis and cannabis products that have an impact on health, or were health-related studies that found medicinal use of cannabis.
Exclusion criteria comprised: (i) editorials, letters, commentaries, surveys, protocols and book chapters; (ii) studies that used social media for recruiting participants; (iii) studies where the full text of the publication was not available; (iv) conference abstracts (iv) studies primarily focused on electronic nicotine delivery systems adapted to deliver cannabinoids; (v) studies that used bots or autonomous systems as the main data source and (vi) studies that focused exclusively on synthetic cannabis.
All studies captured by the search queries listed in Table 1 were uploaded into excel to enable all duplicates to be removed. Following this all titles and abstracts were reviewed independently and in duplicate by CMH and SKH. Records were excluded based on title and abstract screening as well as publication type.
The full text articles that were identified for inclusion following screening process were then independently critiqued by pairs of reviewers using a checklist developed for this study. The purpose of the checklist that we developed for this systematic scoping review was to provide an overall assessment of quality rather than generate a specific score, (S2 Appendix). Assessments of quality in each study were based on evidence of relative quality in the aims or objectives, main findings, data collection method, analytic methods, data source, and evaluation and interpretations of the study. CMH and SKH critiqued all articles, and YB and MC each critiqued a selection of studies to ensure each article had been independently reviewed by two researchers. Where initial disagreement existed between reviewers regarding the inclusion of a study, team members met to discuss the disputed article’s status until consensus was achieved.
Study inclusion
Assessments of quality in each study were based on evaluating each study’s aims and objectives, main findings, data collection and analytic methods, data sources, and evaluation and interpretations of the results. Social media studies were included if there were no major biases affecting the internal, external or construct validity of the study [42]. In doing so, the internal validity of each study was determined by the quality of the data and analytic processes used, the external validity determined by the extent to which the findings can be generalised to other contexts, and the construct validity was ascertained by the extent to which the chosen measurement tool correctly measured what the study aimed to measure (S3 Appendix).
Results
Of the 1556 titles identified in the electronic database searches, 859 duplicate articles were removed, 450 were excluded following the screening of title and abstracts and 195 were excluded based on publication type (i.e., survey, letter, comment, abstract). This screening process provided fifty-two potentially relevant full text primary research studies to be included in the review (Fig 1). Of these, five articles were not able to be retrieved, two out of forty-seven articles had initial disagreement. Upon consensus, five were excluded with reasons (S3 Appendix) using the quality assessment checklist as described above. This provided forty-two papers for inclusion in this systematic scoping review published between 2014 and 2022. Regarding publication type, the majority were journal articles 40/42 (95.2%), and two were conference-based publications 2/42 (4.8%). Although the first study was published eight years ago, nearly two-thirds 24/42 (57%), have been published over the last four years. Table 2 provides a summary of each paper that includes author names, publication year, data source, duration of the study, number of collected posts, number of analysed posts, and the coding or labelling approach used.
Fig 1. PRISMA flow diagram for a systematic scoping review of social media data and cannabis as a medicine.
Table 2. Articles included in the review.
| # | STUDY | SOURCE | DURATION | COLLECTED DATA | ANNOTATED/ANALYSED | CODING/LABELLING APPROACH |
|---|---|---|---|---|---|---|
| 1 | McGregor et al., 2014 [44] | Online forums, Facebook, Twitter, YouTube, Patient- Opinion.org.uk | Not Available | 3,785 items | All data | Manual coding |
| 2 | Cavazos-Rehg, Sowles & Fisher et al., 2015 [100] | February 2014—Mar 2014 | 7,653,738 tweets | 7,000 tweets | Manual coding using crowdsourcing services | |
| 3 | Daniulaityte et al., 2015 [69] | October 2014—December 2014 | 125,255 tweets 27,018 geolocated |
All data | No coding—Use existing geographical fields | |
| 4 | Gonzalez-Estrada et al., 2015 [46] | YouTube | 4–8 June 2014 | 200 most viewed videos | All data | Manual coding |
| 5 | Krauss et al., 2015 [47] | YouTube | 22 January 2015 | 116 Videos | All data | Manual coding |
| 6 | Thompson, Rivara & Whitehill, 2015 [43] | March 2012—July 2013 | 36,939 original tweets 10,000 retweets |
~47,000 tweets | Manual coding | |
| 7 | Cavazos-Rehg, Sowles & Krauss et al., 2016 [49] | January 2015 | 206,854 tweets | 5,000 tweets | Manual coding using crowdsourcing services | |
| 8 | Lamy et al., 2016 [50] | May 2015—July 2015 | 100,182 tweets 26,975 geolocated |
3,000 tweets | Manual coding | |
| 9 | Mitchell et al., 2016 [51] | Online Forums | October 2014 | 268 forum threads | 46 threads 880 posts |
Manual coding |
| 10 | Andersson, Persson & Kjellgren, 2017 [52] | Online Forums | 18–19 April 2016 | 32 topics | All data | Manual coding |
| 11 | Dai & Hao, 2017 [72] | August 2015—April 2016 | 1,253,872 post traumatic stress disorder (PTSD) tweets 66,000 cannabis PTSD tweets |
2,000 labelled tweets, remaining tweets by machine learning |
Automated coding using machine learning | |
| 12 | Greiner, Chatton & Khazaal, 2017 [53] | Online Forums | November 2014—March 2015 | 717 posts | All data | Manual coding |
| 13 | Turner & Kantardzic, 2017 [73] | August 2015—April 2016 | 40,509 geolocated tweets | 2,000 labelled, remaining tweets by machine learning | Automated coding using machine learning | |
| 14 | Westmaas, McDonald & Portier, 2017 [74] | Online Forums | January 2000—December 2013 | 468,000 posts | All data | Automated coding using topic modelling |
| 15 | Yom-Tov & Lev-Ran, 2017 [75] | Bing search engine | November 2016—April 2017 | Not available | All data | Automated coding using lexicons |
| 16 | Cavazos-Rehg, Krauss & Sowles et al., 2018 [54] | YouTube | 10–11 June 2015 | 83 videos | All data | Manual coding |
| 17 | Glowacki, Glowacki, & Wilcox., 2018 [76] | August 2016—October 2016 | 73,235 tweets | All data | Automated coding using topic modelling | |
| 18 | Meacham, Paul & Ramo, 2018 [77] | January 2010–December 2016 | ~400,000 posts | All data | Automated coding using lexicons and pattern matching | |
| 19 | Leas, Nobels & Caputi et al., 2019 [66] | Google Trends | January 2004—April 2019 | Not available | Summary data | No coding–used Google trends data |
| 20 | Meacham, Roh & Chang et al., 2019 [55] | January 2017—December 2017 | 193 dabbing questions and/or posts | All data | Manual coding | |
| 21 | Nasralah, El-Gayar & Wang, 2019 [70] | January 2015—February 2019 | 20,609 tweets | All data | Automated coding supplied by an analytics company | |
| 22 | Pérez-Pérez et al., 2019 [83] | February 2018—August 2018 | 24,634 tweets | All data | Automated coding using lexicons | |
| 23 | Shi et al., 2019 [67] | Google Trends; Buzzsumo | January 2011—July 2018 | Not available | Summary data | No coding–used Google trends data |
| 24 | Allem, Escobedo & Dharmapuri, 2020 [78] | May 2018—December 2018 | 19,081,081 tweets | 60,861 non-bots 8,874 bots |
Automated coding using rule-based methods | |
| 25 | Janmohamed et al., 2020 [85] | Blogs, news articles, forums, comments, professional reviews, Facebook posts | August 2019—April 2021 | 4,027,172 documents and/or blog entries | All data | Automated coding using topic modelling |
| 26 | Jia et al., 2020 [56] | Google, Facebook, YouTube | September 2019 | 51 Google websites 126 Facebook posts 37 YouTube videos |
All data | Manual coding |
| 27 | Leas, Hendrickson & Nobels et al., 2020 [57] | January 2014—August 2019 | 104,917 reddit posts | 3,000 initial data 376 as testimonials |
Manual coding | |
| 28 | Merten, Gordon & King et al., 2020 [58] | January 2018—December 2018 | 1,280 pins | 226 pins | Manual coding | |
| 29 | Mullins et al., 2020 [71] | June 2017—July 2017 | 941 tweets | All data | Automated coding supplied by an analytics company | |
| 30 | Saposnik & Huber, 2020 [68] | Google Trends | January 2004—December 2019 | Not available | Summary data | No coding–used Google trends data |
| 31 | Song et al., 2020 [59] | GoFundMe | January 2012—December 2019 | 1,474 campaigns | 500 campaigns | Manual coding |
| 32 | Tran & Kavuluru, 2020 [84] | Reddit and FDA comments | January 2019—April 2019 | 64,099 reddit comments 3,832 FDA (U.S. Food & Drug Administration) comments |
All data | Automated coding using rule-based methods |
| 33 | van Draanen et al., 2020 [79] | January 2017—June 2019 | 1,200,127 tweets | All data | Automated coding using Topic modelling | |
| 34 | Zenone, Snyder & Caul, 2020 [65] | GoFundMe | January 2017—May 2019 | 155 campaigns | All data | Manual coding |
| 35 | Pang et al., 2021 [62] | December 2019—December 2020 | 17,238 tweets | 1,000 tweets | Manual coding | |
| 36 | Rhidenour et al., 2021 [63] | January 2008—December 2018 | 974 posts | All data | Manual coding | |
| 37 | Smolev et al., 2021 [64] | November 2018—November 2019 | 7,694 posts | All data | Manual coding | |
| 38 | Zenone, Snyder & Crooks, 2021 [61] | GoFundMe | June 2017—May 2019 | 164 campaigns | All data | Manual coding |
| 39 | Soleymanpour, Saderholm & Kavuluru, 2021 [80] | July 2019 | 2,200,000 tweets | 2,000 labelled, remaining data by machine learning |
Automated coding using machine learning | |
| 40 | Allem et al. 2022 [81] | January 2020—September 2020 | 353,353 tweets | 1,092 labelled, remaining data by classifiers |
Automated coding using rule-based methods | |
| 41 | Meacham, Nobles, Tompkins & Thrul, 2022 [60] | Reddit (2 subreddits) | December 2015—August 2019 | 16,791 opioid recovery subreddits 159,994 opioid use subreddits |
200 posts labelled manually and analysed 908 opioid recovery subreddits 4,224 opioid use subreddits |
Manual coding and automated coding using rule-based methods |
| 42 | Turner, Kantardzic, & Vickers-Smith, 2022 [82] | 567,850 tweets collected – | 5,496 tweets manually labelled 167,755 personal use tweets 143,322 commercial tweets labelled by classifier |
Automated coding using machine learning |
Adapted from: Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 2021;372:n71. doi: 10.1136/bmj.n71. For more information, visit: http://www.prisma-statement.org/.
Data collection and annotation
The largest manually annotated dataset that contained 47,000 labelled tweets was published by Thompson et al. in 2015 [43]. This paper was one of 22 studies included in this review (52.4%) that either collected a limited number of data points, or sampled their collected data, and manually coded the data to gain an in-depth understanding of the domain [44–65]. Four of the 42 studies (9.5%) used existing meta-data including Google trends summary data [66–68], and geo-location data [69]. Two (4.8%) studies used data that was manually coded using crowdsourcing services [45,49], and two (4.8%) used automated coding supplied by a social media analytics company [70,71]. Fifteen of the forty-two studies (35.7%) used automated methods for labelling data, which included the use of machine learning, lexicon, and rule-based algorithms [60,72–85]. Automated coding was increasingly used as an analytic tool for social media data on this topic from 2017 onward (Table 2).
Data analysis
For the studies that were manually labelled, analysis included the calculation of proportions and trends, and the development of repeating and emergent themes. [43,44,46,47,49,50,54–56,60,61,64,65,82,86–94]. Leas, Nobles et al. 2019, Shi, Brant et al. 2019, and Saposnik and Huber 2020, reported on Google trends data that delivered an index of Google search trends over time [66–68]. Daniulaityte, Nahass et al. 2015, processed Twitter data that contained existing geographical fields to identify geolocation at source [69]. The studies that utilised a large volume of data used advanced computational methods, which included sentiment analysis, topic modelling, and rule-based text mining [60,72,77–82,85]. The use of sentiment analysis in the [60,80,95] enabled the analysis of people’s sentiments, opinions, and attitudes. Topic modelling in the [74,76,79,80,85] studies enabled the development of themes via automatic machine learning methods. The use of rule-based text mining such as found in the [60,72,83,96,97] studies enabled the classification of posts into pre-existing health-related categories.
Research themes
In this review, we categorized the forty-two research articles into six broad themes. Themes were based on the research questions motivating the studies, where each paper was classified as belonging a primary theme, based on alignment with the research aims (Table 3).
Table 3. Themes in reviewed articles.
| THEME | STUDY | AIM |
|---|---|---|
| General cannabis related conversations (n = 9) |
Cavazos-Rehg et al., 2015 [100] | Topic analysis of cannabis sentiment |
| Thompson, Rivara & Whitehill, 2015 [43] | Content analysis of cannabis-related conversations | |
| Greiner, Chatton & Khazaal, 2017 [53] | Analysis of self-help online forums related to cannabis use and addiction | |
| Turner & Kantardzic 2017 [73] | Examination of geographical impact on cannabis conversations; topic analysis, and social networks analysis | |
| Cavazos-Rehg et al., 2018 [54] | Content analysis of YouTube cannabis reviews and examine exposure to these reviews and their impact on cannabis use. | |
| Allem, Escobedo & Dharmapuri, 2020 [78] | Topic analysis of cannabis-related Twitter conversations to capture and describe the public’s recent experiences | |
| Van Draanen et al., 2020 [79] | Topic and sentiment analysis of geographical impact on cannabis conversations; | |
| Rhidenour et al., 2021 [63] | Exploration of Veterans discussions regarding their cannabis use on Reddit | |
| Allem et al., 2022 [78] | Content analysis of Twitter for cannabis related motivations and health consequence use | |
| Cannabis mode of use (n = 7) |
Daniulaityte et al., 2015 [69] | Thematic analysis of concentrate use (‘dabs’) conversations and examine geographical impact on cannabis |
| Krauss et al., 2015 [47] | To explore the content of cannabis dabbing-related videos on YouTube | |
| Cavazos-Rehg et al., 2016 [49] | Thematic analysis of dabbing conversations to investigate the consequences of dabbing high-potency cannabis | |
| Lamy et al., 2016 [50] | Thematic analysis of edibles conversations and examine geographical impact on Cannabis | |
| Meacham, Paul & Ramo, 2018 [77] | Analysis of discussions of emerging and traditional forms of cannabis use | |
| Meacham et al., 2019 [55] | Thematic analysis of dabbing questions and responses | |
| Janmohamed et al.,2020 [85] | Topic analysis of vaping narrative before and during COVID-19 pandemic | |
| Cannabis for a specific condition (n = 6) |
Mitchell et al., 2016 [51] | Content analysis of posts about cannabis for ADHD |
| Dai & Hao, 2017 [72] | Analysis of cannabis use for PTSD and the geographical impacts on cannabis use | |
| Shi et al., 2019 [67] | Trends in use of cannabis for cancer and analysis of popular cannabis for cancer news | |
| Jia et al., 2020 [56] | Content analysis of cannabis & glaucoma related posts | |
| Zenone, Snyder & Caul, 2020 [65] | Content analysis of crowdfunding cancer campaigns | |
| Pang et al., 2021 [62] | Thematic analysis of pregnancy & cannabis related posts | |
| Cannabis as a treatment option for illness and disease (n = 12) |
McGregor et al., 2014 [44] | To analyse the ophthalmic content of social media platforms |
| Gonzalez-Estrada et al., 2015 [46] | Content analysis of asthma related YouTube videos | |
| Andersson, Persson, Kjellgren, 2017 [52] | Thematic analysis of cluster headaches and migraines conversation | |
| Westmaas, McDonald & Portier, 2017 [74] | Topic analysis of smoking related conversations on a cancer survivor forum | |
| Glowacki et al.,2018 [76] | Topic modelling of opioid related tweet | |
| Nasralah, El-Gayar & Wang, 2019 [70] | To understand the concerns of opioid-addicted users | |
| Pérez-Pérez et al., 2019 [83] | To characterize the bowel disease community on Twitter | |
| Mullins et al., 2020 [71] | Analysis of common pain discussion topics | |
| Saposnik & Huber, 2020 [68] | Analysis of trends in web searches for the cause and treatments of autism spectrum disorder | |
| Song et al., 2020 [59] | Analysis of patient’s perspective for using complementary and alternative medicine or declining conventional cancer therapy | |
| Smolev et al., 2021 [64] | Thematic analysis of brachial plexus injury Facebook conversation | |
| Meacham, Nobels et al., 2022 [60] | Analysis of active opioid use subreddit and opioid recovery subreddits | |
| Cannabidiol (CBD) related posts (n = 7) |
Merten et al., 2020 [58] | Analysis of how CBD is portrayed on Pinterest |
| Zenone, Snyder & Crooks, 2021 [61] | Analysis of CBD information pathways | |
| Leas et al., 2019 [66] | Analysis of public interest trends in CBD | |
| Leas et al., 2020 [57] | Analysis of reasons for CBD consumption | |
| Tran & Kavuluru, 2020 [84] | To examine the remedial effect and modes of use of CBD | |
| Soleymanpour, Saderholm & Kavuluru, 2021 [80] | Content analysis of marketing claims for CBD in Twitter | |
| Turner et al 2022 [82] | Content analysis of personal and commercial tweets of cannabidiol related tweets | |
| Adverse drug reactions and adverse effects (n = 1) |
Yom-Tov & Lev-Ran, 2017 [75] | Prevalence of internet search engine queries relating to the topic of adverse reactions and cannabis use. |
General cannabis-related conversations
Nine studies were included in the theme relating to cannabis-related conversations (Table 4). The main keywords used in these studies included general terms such as ‘cannabis’, ‘marijuana’, ‘pot’, and ‘weed’. The major aim of these studies was to either identify topics of conversations regarding cannabis, or to examine the role of normative and valence information in the perception of medicinal cannabis. These studies are included because they reported on conversations around cannabis use for medical purposes, the valence associated with perceptions of health benefits of cannabis, and reports of adverse effects. For example, a study on veterans use of cannabis found that cannabis is used to self-medicate a number of health issues, including Post-Traumatic Stress Disorder (PTSD), anxiety and sleep disorder [94]. Seven of the studies used Twitter as a data source [43,73,78,87,96,98,99], one examined the content of YouTube videos about cannabis [100], one investigated online self-help forums [88] and another used Reddit data [94].
Table 4. General cannabis related conversations.
| STUDY | AIM | HEALTH-RELATED EFFECTS/CLAIMS | DATA IDENTIFICATION |
|---|---|---|---|
| Cavazos-Rehg, Krauss et al., 2015 [100] | To examine the sentiment and themes of cannabis-related tweets from influential users and to describe the users’ demographics. | A common theme of pro tweets was that cannabis has health benefits. Anti-cannabis posts spoke of the harm experienced in using cannabis. 77% of posts had positive sentiments, with 12 times higher reach than other posts. | Cannabis-related keywords |
| Thompson, Rivara et al., 2015 [43] |
To examine cannabis- related content in Twitter, especially content tweeted by adolescent users, and to examine any differences in message content before and after the legalisation of recreational cannabis in two US states. | More tweets described perceived positive benefits of cannabis use, including relaxation and escaping life problems. Tweets described cannabis as less harmful than other drugs or as not harmful at all and suggested its medical role for conditions such as depression and cancer. Less than 1% of tweets expressed a concern about cannabis use. | Cannabis-related keywords |
| Greiner, Chatton et al., 2017 [53] |
To investigate online content of cannabis use/addiction self-help forums. | Self-help forums on cannabis share a theme around cannabis users seeking help for addiction and withdrawal issues. | |
| Turner et al., 2017 [73] | To examine if cannabis legalisation policies impact Twitter conversations and the social networks of users contributing to cannabis conversations. | Medical cannabis was a major topic in the conversations. | Cannabis-related keywords |
| Cavazos-Rehg, Krauss et al., 2018 [54] |
To investigate cannabis product reviews and the relationship between exposure to product reviews and cannabis users’ demographics and characteristics. | Product reviews promoted cannabis for helping with relaxation, pain relief, sleep, improving emotional well-being. Medical cannabis users are more likely to be exposed to cannabis product reviews. | |
| Allem, Escobedo et al., 2020 [78] |
To identify and describe cannabis-related topics of conversation on Twitter, and the public health implications of these. | Health and medicine were the third most prevalent topic of the 12 topics identified in the data. Posts suggested that cannabis could help with cancer, sleep, pain, anxiety, depression, trauma, and posttraumatic stress disorder. Health-related posts from social bots were almost double that of genuine posts. | Cannabis-related keywords |
| Van Draanen et al., 2020 [79] |
To examine differences in the sentiment and content of cannabis-related tweets in the US (by state cannabis laws) and Canada. | Medical cannabis use was one of the main topics of conversations in cannabis-related tweets from both countries. | Tweets filtered on US and Canada geolocation and then further filtered on cannabis-related keywords |
| Rhidenour et al., 2021 [63] |
To explore Veterans’ Reddit discussions regarding their cannabis use. | Over a third of the Reddit posts described the use of medical cannabis as an aid for psychological and physical ailments. Overall, veterans discussed how the use of medical cannabis reduced PTSD symptoms, anxiety, and helped with their sleep. | The veteran subreddit |
| Allem, Majmundar et al., 2022 [81] |
To determine the extent to which a medical dictionary could identify cannabis-related motivations for use and health consequences of cannabis use. | There were posts related to both health motivations and consequences of cannabis use. The health-related posts included issues with the respiratory system, stress to the immune system, and gastrointestinal issues, among others. | Cannabis-related keywords |
Cannabis mode of use
Seven studies were included in the theme relating to the mode of use of cannabis as a medicine (Table 5). These studies collected data using keywords such as ‘vape,’ ‘vaping’, ‘dabbing’, and ‘edibles’. Conversations around modes of use revealed a theme about lacking, seeking, or sharing knowledge about health consequences of the modes of use. Another theme was around the perceived health benefits of cannabis and the various modes of use of cannabinoids that included sleep improvement and relaxation resulting from dabbing oils [49] or consuming ‘edibles’ [50]. The findings suggest that for emerging modes of use such as dabbing, where the availability of evidence-based information is limited, people seek information from others’ experiences.
Table 5. Cannabis mode of use.
| STUDY | AIM | HEALTH-RELATED EFFECTS/CLAIMS | DATA IDENTIFICATION |
|---|---|---|---|
| Daniulaityte et al., 2015 [69] |
To explore Twitter data on concentrate (‘dabs’) use and examine the impact of cannabis legalisation policies on concentrate use conversations. | Twitter data suggest popularity of dabs in the US states with legalised recreational/medical use of cannabis. Dabbing as an emerging mode of use could carry significant health risks. | Dab-related keywords for U.S. location |
| Krauss, Sowles et al., 2015 [47] |
To explore the content of cannabis dabbing-related videos on YouTube. | Only 21% of videos contained warnings about dabbing, such as preventing explosions, injury, or negative side effects. 22% of videos specifically mentioned medical cannabis or getting ‘medicated’, either in the video itself or in the accompanying text description. | Dabbing related keywords |
| Cavazos-Rehg, Sowles et al., 2016 [49] |
To study themes of dabbing conversations and to investigate the consequences of high-potency cannabis consumption. | The fourth theme (of seven) was about cannabis helping with relaxation, sleep or solving problems. Extreme effects were both physiological and psychological. The most common physiologic effects were passing out and respiratory, with coughing the most common respiratory effect. | Dabbing related keywords |
| Lamy, Daniulaityte et al., 2016 [50] |
To study themes of edibles conversations and examine legalisation policies’ impact on cannabis-related tweeting activity. | Twitter data suggest mostly positive attitudes toward cannabis edibles. Positive tweets describe the quality of the ‘high’ experienced and how cannabis edibles facilitate falling asleep. Negative tweets discuss the unreliability of edibles’ THC dosage and delayed effects that were linked to over-consumption, which could lead to potential harmful consequences. | Cannabis edible-related keywords |
| Meacham, Paul et al., 2018 [77] |
To analyse discussions of emerging and traditional forms of cannabis use. | Less than 2% of conversations described adverse effects. The most mentioned adverse effects were anxiety-related in the context of smoking, edibles, and butane hash oil, and ‘cough’ for vaping and dabbing. | A cannabis specific subreddit on various modes of use |
| Meacham, Roh et al., 2019 [55] |
To study themes of dabbing- related questions and responses. |
Health concerns are the fifth category of dabbing questions—including respiratory effects, anxiety, and vomiting. Respondents in these conversations usually spoke from personal experience. | Search for ‘Dab’ and ‘question’ on cannabis subreddits |
| Janmohamed et al.,2020 [85] |
To map temporal trends in the web-based vaping narrative, to indicate how the narrative changed from before to during the COVID-19 pandemic. | The emergence of a vape-administered CBD treatment narrative around the COVID-19 pandemic. | Vape-related keywords |
Cannabis as a medicine for a specific health issue
Six studies were included in the theme relating to cannabis as a medicine for a specific health issue (Table 6). These studies investigated conversations around the use of cannabis or cannabidiol (CBD) for a specific health issue. The health conditions included glaucoma [56], PTSD [72], cancer [65,101], Attention Deficit Hyperactivity Disorder (ADHD) [91], and pregnancy [92]. These studies mostly discovered that conversations claimed benefits of cannabis as an alternative treatment for these health conditions, although mentions of harm, and both harm and therapeutic effects, were also present [91].
Table 6. Cannabis as a medicine for a specific health issue.
| STUDY | AIM | HEALTH-RELATED EFFECTS/CLAIMS | DATA IDENTIFICATION |
|---|---|---|---|
| Mitchell et al., 2016 [51] |
To examine the content of online forum threads on ADHD and cannabis use to identify trends about their relation, particularly regarding therapeutic and adverse effects of cannabis on ADHD. | Of all individual posts, 25% indicated that cannabis is therapeutic for ADHD, as opposed to 8% that claim it is harmful, 5% that it is both therapeutic and harmful, and 2% that it has no effect on ADHD. | Cannabis and ADHD keywords |
| Dai & Hao, 2017 [72] |
To evaluate factors that could impact public attitudes to PTSD related cannabis use. | Of all PTSD tweets, 5.3% were related to cannabis use and these tweets predominantly supported cannabis use for PTSD. | Cannabis and PTSD keywords |
| Shi et al., 2019 [67] |
To characterize trends in use of cannabis for cancer and analysis of content and impact of popular news about cannabis for cancer. | Between 2011–2018, the relative google search volume of ’cannabis cancer’ queries increased at a rate ten times faster than ’standard cancer therapies’ queries. Popular ‘false news’ stories had a much higher engagement than contrary ‘accurate’ news stories. | Cannabis vs standard therapies for cancer |
| Jia, Mehran et al., 2020 [56] |
To analyze the content quality and risk of readily available online information regarding cannabis and glaucoma. | While the American Glaucoma Society recommends against cannabis use for glaucoma treatment, 21% of Facebook, 24% of Google, and 59% of YouTube search results were pro cannabis use for glaucoma treatment. | Cannabis and Glaucoma keywords |
| Zenone et al., 2020 [65] |
To use crowdfunding campaigns to understand how cannabidiol is represented/misrepresented as a cancer-related care. | CBD use was reported to reduce the side effects of conventional treatments or can be used with other complementary cancer treatments. Reported uses included stimulating appetite, general pain relief, assisting with sleep, countering nausea, or general recovery purposes. Most campaigners presented definite efficacy of CBD for pain or symptom management. | CBD term variants and ‘cancer’ |
| Pang et al., 2021 [62] |
To examine cannabis and pregnancy-related tweets over a 12-month period. | Thirty-six percent mentioned safety during pregnancy, 2.3% of posts asked about safety during postpartum, and 2.7% of posts expressed use of cannabis during pregnancy to help with pregnancy symptom i.e., to help with morning sickness, nausea, vomiting, headaches, pain, stress, and fatigue. The authors conclude that health providers discuss risks and provide official information about cannabis use in pregnancy. | Cannabis and pregnancy related keywords |
Cannabis as a medicine as part of discourse on illness and disease
Twelve studies were included in the theme relating to cannabis as a medicine as part of discourse on illness and disease (Table 7). In this theme, the research focus was on social media topics relating to management and treatment options for a range of health conditions rather than on medicinal cannabis per se. Health conditions discussed included inflammatory and irritable bowel disease [102], opioid use disorder [70,103,104], pain [71], ophthalmic disease [44], cluster headache and migraine [86], asthma [105], cancer [93,106], autism disorder [107], and brachial plexus injury [64].
Table 7. Cannabis as a medicine as part of discourse on illness and disease.
| STUDY | AIM | HEALTH-RELATED EFFECTS/CLAIMS | DATA IDENTIFICATION |
|---|---|---|---|
| McGregor et al., 2014 [44] | To analyse the ophthalmic content of social media platforms. | Treatment was one of the main themes, with complementary therapy featuring most prominently on Twitter, where 87% of posts on complementary therapy described the use of medical cannabis for glaucoma. | Glaucoma patient forums and glaucoma keywords |
| Gonzalez-Estrada et al., 2015 [46] |
To determine the educational quality of YouTube videos for asthma. | The most common video content was regarding alternative medicine (38%) and included cannabis as well as live fish ingestion; salt inhalers; raw food, vegan, gluten-free diets; yoga; Ayurveda; reflexology; acupressure; and acupuncture; and Buteyko breathing. | Asthma related videos |
| Andersson et al., 2017 [52] |
To understand the use of non-established or alternative pharmacological treatments used to alleviate cluster headaches and migraines. | Cannabis was discussed for its potential to alleviate symptoms or reduce the frequency of migraine attacks. Some discussed use of cannabis for other purposes, but experienced additional benefits for headache symptoms. The effects of self-treatment with cannabis appeared more contradictory and complex than treatment with other substances. | Search for ‘treatment migraines’ on three alternative treatment online forums |
| Westmaas et al., 2017 [74] |
To investigate contexts in which smoking, or quitting is discussed in a cancer survivor network. | Use of cannabis (primarily for nausea), was the fourth topic. | Smoking/cessation-related keywords from the Cancer Survivors Network (CSN) |
| Glowacki et al.,2018 [76] |
To identify public reactions to the opioid epidemic by identifying the most popular topics. | Mentions of cannabis as an effective alternate to opioids for managing pain. | Opioid-related keywords |
| Nasralah et al., 2019 [70] |
To understand the concerns of opioid-addicted users. | Cannabis was found in two of five main themes: ‘In recovery’ and ‘taking illicit drugs’ for pain management. | Users who self-identified as addicted to, or previously addicted to, opioids |
| Pérez-Pérez et al., 2019 [83] |
To characterize the bowel disease community on Twitter. | Medical cannabis was the fourth most mentioned term in the bowel disease (BD) community. Medical cannabis and its components were the most discussed drug, with mentions of its benefits in mitigating common BD symptoms. | Inflammatory bowel disease, Irritable bowel disease keywords |
| Mullins et al., 2020 [71] |
To examine pain-related tweets in Ireland over a 2-week period. |
The fourth most occurring keyword was cannabis. Ninety percent of cannabis related tweets were non-personal, with highly positive sentiment and highest number of impressions per tweet. Cannabis had by the largest number of tweets aimed at generating awareness. | Pain-related keywords |
| Saposnik & Huber, 2020 [68] |
To analyse of trends in web searches for the cause and treatments of autism spectrum disorder (ASD). | ASD and cannabis web searches have continued to rise since 2009. Apart from searches on Applied Behavioral Analysis and Autism, cannabis and ASD have been searched more than other ASD interventions since 2013. | ‘Autism’ and key search terms for causes and treatments of autism |
| Song et al., 2020 [59] |
To understand the cancer patient’s perspective for using complementary and alternative medicine, or for declining traditional cancer therapy. | Cannabidiol oil was 10th amongst the most used alternative treatments. | Twenty most prevalent cancers in the U.S. and a list of most frequently utilised complementary and alternative medicine including yoga, herbal, and meditation. |
| Smolev et al., 2021 [64] | To analyse themes of brachial plexus injury Facebook conversations. | There were 313 posts regarding cannabinoids as a preferred alternative pain management medication. | ‘traumatic brachial plexus injury’ keyword |
| Meacham, Nobles et al. 2022 [60] | To assess and compare active opioid use subreddit and an opioid recovery subreddit: 1) the proportion of posts that mention cannabis, 2) the most frequently-used words and phrases in posts that mention cannabis, and 3) motivations for cannabis use in relation to opioid use as described in cannabis-related posts. | All posts (title and content) and associated metadata posted from December 2015 to August 2019 (45 months) on an opioid use subreddit and an opioid recovery subreddit were downloaded from the Pushshift Reddit database [34] via Google Big Query. Data were analyzed in R Studio version 1.2.5019. Duplicate posts were removed (1.5% of posts), which were identified with the ‘duplicated’ base R function applied to post text. | weed, cannabis, marijuana, pot, reefer, ganja, thc, and cbd |
Cannabidiol (CBD)
There were seven studies in the cannabidiol category [61,80,82,89,90,108,109] (Table 8). These studies concentrated on conversations related to the benefits of CBD products, product sentiment (positive, negative, or neutral), the factors that impact on a person’s decision to use CBD products, and the trends in therapeutic use of CBD.
Table 8. Cannabidiol (CBD) related posts.
| STUDY | AIM | HEALTH-RELATED EFFECTS/CLAIMS | DATA IDENTIFICATION |
|---|---|---|---|
| Merten, Gordon et al., 2020 [58] | To analyse how CBD is portrayed on Pinterest. | Most pins (57.5%) did not make a specific health benefit claim yet 42.5% claimed mental, physical, or both mental and physical health benefits. | ‘cannabidiol’ or ‘CBD’ |
| Zenone, Snyder et al., 2021 [61] | To analyse the CBD informational pathways which bring consumers to CBD for medical purposes. | Self-directed research was the most common pathway to CBD. The proposed uses of CBD were for cancer, seizure-inducing diseases/conditions, joint/inflammatory diseases, mental health disorders, nervous system diseases, and autoimmune diseases. | ‘cannabidiol’ or ‘CBD’ |
| Leas, Nobel et al., 2019 [66] | To analyse public interest trends in CBD using Google Trends. | Searches for CBD exceed searches for yoga and around half as much as searches for dieting. | ‘cannabidiol’ or ‘CBD’ vs other alternative medicine including diet, yoga, |
| Leas, Hendrickson et al., 2020 [57] | To assess if individuals are using CBD for diagnosable conditions which have evidence-based therapies. | Psychiatric conditions were the most cited diagnosable condition, mentioned in 63.9% of testimonials. The second most cited subcategory was orthopedic conditions (26.4%), followed by sleep (14.6%), neurological (6.9%), and gastroenterological (3.9%) conditions. | CBD subreddit posts |
| Tran & Kavuluru, 2020 [84] | To examine social media data to determine perceived remedial effects and usage patterns for CBD. |
Anxiety disorders and pain were the two conditions dominating much of the discussion surrounding CBD, both in terms of general discussion and for CBD as a perceived therapeutic treatment. CBD is mentioned as a treatment for mental issues (anxiety, depression, stress) and physiological issues (pain, inflammation, headache, sleep disorder, seizure disorders, nausea, and cancer). | CBD subreddit posts |
| Soleymanpour et al., 2021 [80] | To perform content analysis of marketing claims for CBD in Twitter. | Over 50% of CBD tweets appear to be marketing related chatter. Pain and anxiety are the most popular conditions mentioned in marketing messages. Edibles are the most popular product type being advertised, followed by oils. | ‘cbd’, ‘cbdoil’, and ‘cannabidiol’ |
| Turner, Kantardzic et al. 2021 [82] | The objective of this study was to provide a framework for public health and medical researchers to use for identifying and analyzing the consumption and marketing of unregulated substances using CBD as an exemplar. | There was a significant difference in the sentiment scores between the personal and commercial CBD tweets, the mean sentiment score of the commercial CBD scores was higher than that of the personal CBD score. Pain, anxiety, and sleep had the highest positive sentiment score for both personal and commercial CBD tweets. | ‘CBD’, ‘cannabidiol.’ |
Adverse drug reactions and adverse effects
One paper had a research question that explicitly focused on the detection of adverse events [75] (Table 9) This study explored the prevalence of internet search engine queries relating to the topic of adverse reactions and cannabis use. Seven other studies contained mentions of adverse effects which were associated with cannabis use [47,49,51,53,55,62,77,81], however these papers were not included under this theme, as their research questions were not centered around the explicit investigation of adverse events.
Table 9. Cannabis related to adverse drug reactions and adverse effects.
| STUDY | AIM | HEALTH-RELATED EFFECTS/CLAIMS | DATA IDENTIFICATION |
|---|---|---|---|
| Yom-Tov & Lev-Ran, 2017 [75] |
To check if search engine queries can be used to detect adverse reactions of cannabis use. | A high correlation between the side effects recorded on established reporting systems and those found in the search engine queries. These side effects included anxiety, depression-related symptoms, psychotic symptoms such as paranoia and hallucinations, cough, and other symptoms. | Cannabis related keywords |
Discussion
Currently, there exist systematic reviews of cannabis and cannabinoids for medical use based on clinical efficacy outcomes from randomised controlled trials [18] and reviews on the use of social media for illicit drug surveillance [110]. However, following searches on PROSPERO and the databases listed above, to our knowledge, this paper constitutes the first systematic scoping review examining studies that used user-generated online text to understand the use of cannabis as a medicine in the global community.
Our scoping review found that the use of social media and internet search queries to investigate cannabis as a medicine is a rapidly emerging area of research. Over half of the studies included in this review were published within the last four years (24, 57.1%), this reflects not only increase community interest in the therapeutic potential of cannabinoids, but also world-wide trends towards cannabis legalisation [4,7–9,111,112]. Regarding social media platforms, Twitter was the data source in eighteen (42.9%) of the forty-two studies, almost three and a half times the number of studies using Reddit (6, 14.3%) and just under three times the number of studies using data from Online forums (5, 11.9%). Three (7.14%) GoFundMe studies and three (7.14%) Google Trends studies were also included in the review. Hence, much of the data in this systematic review comprised posts from the Twitter platform. Several factors may explain this finding, firstly Twitter is real-time in nature, it has a high volume of messages, and it is publicly accessible. These factors makes it a useful data source for public health surveillance [113].
Regarding the subjects of the studies, twelve (28.6%) focused on general user-generated content regarding the treatment of health conditions (glaucoma, autism, asthma, cancer, bowel disease, brachial plexus injury, cluster headaches, opioid disorder). These studies were either explicitly designed to investigate cannabis as a medicine or were studies that generated results that incidentally found cannabis mentioned as an alternative or complementary treatment (either formally prescribed or via self-medication).
Qualitative studies featured in the research, but while their contributions are valuable, especially in the context of hypothesis generation, they tend to be limited by their smaller datasets, which frequently comprise manually annotated samples. The recent emergence of powerful machine learning-based natural language processing (NLP) models suggests that it should be possible to automate the continuous processing of far larger datasets using NLP technologies, built upon the insights gained from initial qualitative studies, and even leveraging their annotated data for training purposes. Recent trends in the social science data landscape have shown a convergence between social science and computer science expertise, where the ability to use computational methods has greatly assisted the collection and validation of robust datasets that can form the basis of deeper social science research [114].
We found much heterogeneity in approaches applied to analyse user-related content, and inconsistent quality in the methodologies adopted. While we endeavored to include as many studies as possible, some of the publications initially identified as suitable for inclusion were not suitable based on a minimum quality requirements checklist (S1 Appendix). This checklist was designed to ensure that selection of data source, choice of platform, data acquisition and preparation, analysis and evaluation delivers data and conclusions that are appropriate for answering the research questions.
The utilisation of user-generated content for health research is subject to several inherent limitations which include; the lack of control that researchers have in relation to the credibility of information, the frequently unknown demographic characteristics and geographical location of individuals generating content, and the fact that social media users are not necessarily representative of the wider community [115]. Furthermore, the uniqueness, volume, and salience of social media data has implications that need to be considered when used for health information analysis [116]. Volume is usually inversely related to salience; a platform such as Twitter has a very high volume of information, much of which is not highly pertinent for the analysis of an effect, whereas the information contained in a blog will contain less volume, but will be more salient for analysis. Notwithstanding these limitations, user-generated content comprises large-scale data that provides access to the unprompted organic opinions and attitudes of cannabis users in their own words and is an effective medium through which to gauge public sentiment. To date, insights regarding cannabis as medicine have gained primarily through surveys or focus groups which have their own limitations regarding the format of data collection and potential bias in participant recruitment. A limitation of this scoping review was the lack of inclusion of a computational database such as IEEE Xplore in the search strategy, and the exclusion of the search terms ‘infodemiology’ and ‘infoveillance.’ Infodemiology and infoveillance studies explicitly use web-based data for research, and IEEE Xplore is a repository that contains technical papers and documents relating to computer science. However, our search was systematic, comprehensive and IEEE Xplore is Scopus-indexed, and we expect data loss to be minimal.
Conclusion
Our systematic scoping review reflects a growing interest in the use of user-generated content for public health surveillance. It also demonstrates there is a need for the development of a systematic approach for evaluating the quality of social media studies and highlights the utility of automatic processing and computational methods (machine learning technologies) for large social media datasets. This systematic scoping review has shown that user-generated content as a data source for studying cannabis as a medicine provides another means to understand how cannabis is perceived and used in the community. As such, it is another potential ‘tool’ with which to engage in pharmacovigilance of, not only cannabis as a medicine, but also other novel therapeutics as they enter the market.
Supporting information
(DOCX)
(DOCX)
(DOCX)
(DOCX)
(DOCX)
(XLSX)
Data Availability
All relevant data are within the manuscript and its Supporting Information files.
Funding Statement
This systematic scoping review was supported by the Australian Centre for Cannabinoid Clinical and Research Excellence (ACRE), funded by the National Health and Medical Research Council (NHMRC) through the Centre of Research Excellence scheme (NHMRC CRE APP1135054) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
References
- 1.Russo EB. History of cannabis and its preparations in saga, science, and sobriquet. Chemistry and Biodiversity. 2007;4(8):1614–48. doi: 10.1002/cbdv.200790144 [DOI] [PubMed] [Google Scholar]
- 2.Bridgeman MB, Abazia DT. Medicinal cannabis: history, pharmacology, and implications for the acute care setting. Pharmacy and therapeutics. 2017;42(3):180. doi: 10.1371/journal.pone.0089566 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Grinspoon L, Bakalar JB. Marihuana: the forbidden medicine. New Haven, USA: Yale University Press; 1993. [Google Scholar]
- 4.Kalant H. Medicinal use of cannabis: history and current status. Pain Research and Management. 2001;6(2):80–91. doi: 10.1155/2001/469629 [DOI] [PubMed] [Google Scholar]
- 5.Taylor S. Medicalizing cannabis—Science, medicine and policy, 1950–2004: An overview of a work in progress. Drugs: Education, Prevention and Policy. 2008;15(5):462–74. doi: 10.1080/09687630802114038 [DOI] [Google Scholar]
- 6.Musto DF. The marihuana tax act of 1937. Archives of General Psychiatry. 1972;26(2):101–8. doi: 10.1001/archpsyc.1972.01750200005002 [DOI] [PubMed] [Google Scholar]
- 7.EMCDDA. Cannabis policy: status and recent developments Lisbon, Portugal: The European Monitoring Centre for Drugs and Drug Addiction; 2021 [cited 2021 August]. Available from: https://www.emcdda.europa.eu/publications/topic-overviews/cannabis-policy/html_en.
- 8.Shover CL, Humphreys K. Six policy lessons relevant to cannabis legalization. Am J Drug Alcohol Abuse. 2019;45(6):698–706. Epub 2019/03/15. doi: 10.1080/00952990.2019.1569669 ; PubMed Central PMCID: PMC6745015. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.CPFG. Home Office Circular 1 November 2018: Rescheduling of cannabis-based products for medicinal use in humans. In: Unit CDaA, editor. London, United Kingdom: Crime, Policing, and Fire Group (CPFG); 2018. [Google Scholar]
- 10.National Academies of S, Medicine E. The health effects of cannabis and cannabinoids: the current state of evidence and recommendations for research. 2017. [PubMed] [Google Scholar]
- 11.Hall W. Medical use of cannabis and cannabinoids: questions and answers for policymaking. 2018. [Google Scholar]
- 12.Aguilar S, Gutiérrez V, Sánchez L, Nougier M. Medicinal cannabis policies and practices around the world. International Drug Policy Consortium. 2018;(April):32. [Google Scholar]
- 13.TGA. Access to medicinal cannabis products Canberra, Australia: Therapeutic Goods Administration2021. Available from: Retrieved September, 2021, from https://www.tga.gov.au/access-medicinal-cannabis-products-1.
- 14.National Academies of Sciences EaM. The health effects of cannabis and cannabinoids: the current state of evidence and recommendations for research. 2017. [PubMed] [Google Scholar]
- 15.Pearlson G. Medical marijuana and clinical trials. Weed Science: Cannabis Controversies and Challenges Academic Press; 2020. p. 243–60. [Google Scholar]
- 16.Sarris J, Sinclair J, Karamacoska D, Davidson M, Firth J. Medicinal cannabis for psychiatric disorders: A clinically-focused systematic review. BMC Psychiatry. 2020;20(1):1–14. doi: 10.1186/s12888-019-2409-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Suraev AS, Marshall NS, Vandrey R, McCartney D, Benson MJ, McGregor IS, et al. Cannabinoid therapies in the management of sleep disorders: A systematic review of preclinical and clinical studies. Sleep Medicine Reviews. 2020;53:101339–. doi: 10.1016/j.smrv.2020.101339 [DOI] [PubMed] [Google Scholar]
- 18.Whiting PF, Wolff RF, Deshpande S, Di Nisio M, Duffy S, Hernandez AV, et al. Cannabinoids for medical use: A systematic review and meta-analysis. JAMA—Journal of the American Medical Association. 2015;313(24):2456–73. doi: 10.1001/jama.2015.6358 [DOI] [PubMed] [Google Scholar]
- 19.Schulze-Schiappacasse C, Durán J, Bravo-Jeria R, Verdugo-Paiva F, Morel M, Rada G. Are Cannabis, Cannabis-Derived Products, and Synthetic Cannabinoids a Therapeutic Tool for Rheumatoid Arthritis? A Friendly Summary of the Body of Evidence. JCR: Journal of Clinical Rheumatology. 2021;Publish Ah(00):1–5. doi: 10.1097/rhu.0000000000001745 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Bonomo Y, Souza JDS, Jackson A, Crippa JAS, Solowij N. Clinical issues in cannabis use. British Journal of Clinical Pharmacology. 2018;84(11):2495–8. doi: 10.1111/bcp.13703 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Owens B. The professionalization of cannabis growing. Nature. 2019;572(7771). doi: 10.1038/d41586-019-02527-2 [DOI] [PubMed] [Google Scholar]
- 22.Hallinan CM, Bonomo YA. ’The Rise and Rise of Medicinal Cannabis, What Now? Medicinal Cannabis Prescribing in Australia 2017–2022’. International Journal of Environmental Research and Public Health. 2022;ijerph–1806974. doi: 10.3390/ijerph19169853 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Karanges EA, Suraev A, Elias N, Manocha R, McGregor IS. Knowledge and attitudes of Australian general practitioners towards medicinal cannabis: a cross-sectional survey. British Medical Journal Open. 2018;8(7):e022101. Epub 2018/07/05. doi: 10.1136/bmjopen-2018-022101 ; PubMed Central PMCID: PMC6042562. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Caputi TL. The medical marijuana industry and the use of “research as marketing”. American Journal of Public Health. 2020;110(2):174–5. doi: 10.2105/AJPH.2019.305477 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Ayers JW, Caputi TL, Leas EC. The need for federal regulation of marijuana marketing. Jama. 2019;321(22):2163–4. doi: 10.1001/jama.2019.4432 [DOI] [PubMed] [Google Scholar]
- 26.Bonn-Miller MO, Loflin MJE, Thomas BF, Marcu JP, Hyke T, Vandrey R. Labeling accuracy of cannabidiol extracts sold online. JAMA—Journal of the American Medical Association. 2017;318(17):1708–9. doi: 10.1001/jama.2017.11909 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Hallinan CM, Eden E, Graham M, Greenwood LM, Mills J, Popat A, et al. Over the counter low-dose cannabidiol: A viewpoint from the ACRE Capacity Building Group. Journal of Psychopharmacology. 2021. doi: 10.1177/02698811211035394 [DOI] [PubMed] [Google Scholar]
- 28.Fitzcharles MA, Shir Y, Häuser W. Medical cannabis: Strengthening evidence in the face of hype and public pressure. Cmaj. 2019;191(33):E907–E8. doi: 10.1503/cmaj.190509 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Freeman TP, Hindocha C, Green SF, Bloomfield MAP. Medicinal use of cannabis based products and cannabinoids. BMJ (Online). 2019;365(April):1–7. doi: 10.1136/bmj.l1141 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Graham M, Martin JH, Lucas CJ, Hall W. Translational hurdles with cannabis medicines. 2020;(December 2019):1325–30. doi: 10.1002/pds.4999 [DOI] [PubMed] [Google Scholar]
- 31.US Food and Drug Administration. Framework for FDA’s real world evidence program. 2018. [Google Scholar]
- 32.Nabhan C, Klink A, Prasad V. Real-world Evidence—What Does It Really Mean? JAMA Oncology. 2019;5(6):2019–21. doi: 10.1001/jamaoncol.2019.0450 [DOI] [PubMed] [Google Scholar]
- 33.Hallinan CM, Gunn JM, Bonomo YA. Implementation of medicinal cannabis in Australia: Innovation or upheaval? Perspectives from physicians as key informants, a qualitative analysis. BMJ Open. 2021;11(10):1–12. doi: 10.1136/bmjopen-2021-054044 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Finney Rutten LJ, Blake KD, Greenberg-Worisek AJ, Allen SV, Moser RP, Hesse BW. Online Health Information Seeking Among US Adults: Measuring Progress Toward a Healthy People 2020 Objective. Public Health Reports. 2019;134(6):617–25. doi: 10.1177/0033354919874074 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Gualtieri LN. The doctor as the second opinion and the internet as the first. 2009. p. 2489–98. [Google Scholar]
- 36.Shakeri Hossein Abad Z, Kline A, Sultana M, Noaeen M, Nurmambetova E, Lucini F, et al. Digital public health surveillance: a systematic scoping review. npj Digital Medicine. 2021;4(1):41. doi: 10.1038/s41746-021-00407-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Paul MJ, Sarker A, Brownstein JS, Nikfarjam A, Scotch M, Smith KL, et al. Social Media Mining for Public Health Monitoring and Surveillance. Pacific Symposium on Biocomputing. 2016;21(January):468–79. doi: 10.1142/9789814749411_0043 [DOI] [Google Scholar]
- 38.Arksey H, O’Malley L. Scoping studies: towards a methodological framework. International Journal of Social Research Methodology. 2005;8(1):19–32. doi: 10.1080/1364557032000119616 [DOI] [Google Scholar]
- 39.Pawliuk C., Chau B., Rassekh S.R., McKellar T., H. S. Efficacy and safety of paediatric medicinal cannabis use: A scoping review. Paediatrics & Child Health. 2021;26:228–33. doi: 10.1093/pch/pxaa031 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Munn Z, Peters MDJ, Stern C, Tufanaru C, McArthur A, Aromataris E. Systematic review or scoping review? Guidance for authors when choosing between a systematic or scoping review approach. BMC medical research methodology. 2018;18(1). doi: 10.1186/s12874-018-0611-x [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. PLOS Medicine. 2021;18. doi: 10.1371/journal.pmed.1003583 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Olteanu A, Castillo C, Diaz F, Kıcıman E. Social Data: Biases, Methodological Pitfalls, and Ethical Boundaries. Frontiers in Big Data. 2019;2. doi: 10.3389/fdata.2019.00013 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Thompson L, Rivara FP, Whitehill JM. Prevalence of Marijuana-Related Traffic on Twitter, 2012–2013: A Content Analysis. Cyberpsychology, Behavior, and Social Networking. 2015;18(6):311–9. doi: 10.1089/cyber.2014.0620 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.McGregor F, Somner JEA, Bourne RR, Munn-Giddings C, Shah P, Cross V. Social media use by patients with glaucoma: what can we learn? Ophthalmic and Physiological Optics. 2014;34(1):46–52. doi: 10.1111/opo.12093 [DOI] [PubMed] [Google Scholar]
- 45.Cavazos-Rehg PA, Krauss M, Fisher SL, Salyer P, Grucza RA, Bierut LJ. Twitter chatter about marijuana. Journal of Adolescent Health. 2015;56:139–45. doi: 10.1016/j.jadohealth.2014.10.270 . [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Gonzalez-Estrada A, Cuervo-Pardo L, Ghosh B, Smith M, Pazheri F, Zell K, et al. Popular on YouTube: A critical appraisal of the educational quality of information regarding asthma. Allergy and Asthma Proceedings. 2015;36:e121–e6. doi: 10.2500/aap.2015.36.3890 . [DOI] [PubMed] [Google Scholar]
- 47.Krauss MJ, Sowles SJ, Mylvaganam S, Zewdie K, Bierut LJ, Cavazos-Rehg PA. Displays of dabbing marijuana extracts on YouTube. Drug Alcohol Depend. 2015;155:45–51. doi: 10.1016/j.drugalcdep.2015.08.020 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Thompson L, Rivara FP, Whitehill JM. Prevalence of Marijuana-Related Traffic on Twitter, 2012–2013: A Content Analysis. Cyberpsychology, Behavior, and Social Networking. 2015;18:311–9. doi: 10.1089/cyber.2014.0620 . [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Cavazos-Rehg PA, Sowles SJ, Krauss MJ, Agbonavbare V, Grucza R, Bierut L. A content analysis of tweets about high-potency marijuana. Drug Alcohol Depend. 2016;166:100–8. doi: 10.1016/j.drugalcdep.2016.06.034 . [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Lamy FR, Daniulaityte R, Sheth A, Nahhas RW, Martins SS, Boyer EW, et al. "Those edibles hit hard": Exploration of Twitter data on cannabis edibles in the U.S. Drug Alcohol Depend. 2016;164:64–70. doi: 10.1016/j.drugalcdep.2016.04.029 . [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Mitchell JT, Sweitzer MM, Tunno AM, Kollins SH, Joseph McClernon F. "I use weed for my ADHD": A qualitative analysis of online forum discussions on cannabis use and ADHD. PloS one. 2016;11:1–13. doi: 10.1371/journal.pone.0156614 . [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Andersson M, Persson M, Kjellgren A. Psychoactive substances as a last resort-a qualitative study of self-treatment of migraine and cluster headaches. Harm Reduction Journal. 2017;14:1–10. doi: 10.1186/s12954-017-0186-6 . [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Greiner C, Chatton A, Khazaal Y. Online self-help forums on cannabis: A content assessment. Patient Education and Counseling. 2017;100:1943–50. doi: 10.1016/j.pec.2017.06.001 . [DOI] [PubMed] [Google Scholar]
- 54.Cavazos-Rehg PA, Krauss MJ, Sowles SJ, Murphy GM, Bierut LJ. Exposure to and Content of Marijuana Product Reviews. Prevention Science. 2018;19:127–37. doi: 10.1007/s11121-017-0818-9 . [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Meacham MC, Roh S, Chang JS, Ramo DE. Frequently asked questions about dabbing concentrates in online cannabis community discussion forums. International Journal of Drug Policy. 2019;74:11–7. doi: 10.1016/j.drugpo.2019.07.036 . [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.Jia J, Mehran N, Purgert R, Zhang Q, Lee D, Myers JS, et al. Marijuana and Glaucoma: A Social Media Content Analysis. Ophthalmology Glaucoma. 2020. doi: 10.1016/j.ogla.2020.11.004 [DOI] [PubMed] [Google Scholar]
- 57.Leas EC, Hendrickson EM, Nobles AL, Todd R, Smith DM, Dredze M, et al. Self-reported Cannabidiol (CBD) Use for Conditions With Proven Therapies. JAMA network open. 2020;3:e2020977. doi: 10.1001/jamanetworkopen.2020.20977 . [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58.Merten JW, Gordon BT, King JL, Pappas C. Cannabidiol (CBD): Perspectives from Pinterest. Substance Use & Misuse. 2020;55(13):2213–20. doi: 10.1080/10826084.2020.1797808 [DOI] [PubMed] [Google Scholar]
- 59.Song S, Cohen AJ, Lui H, Mmonu NA, Brody H, Patino G, et al. Use of GoFundMe® to crowdfund complementary and alternative medicine treatments for cancer. Journal of Cancer Research and Clinical Oncology. 2020;146:1857–65. doi: 10.1007/s00432-020-03191-0 . [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60.Meacham MC, Nobles AL, Tompkins DA, Thrul J. "I got a bunch of weed to help me through the withdrawals": Naturalistic cannabis use reported in online opioid and opioid recovery community discussion forums. PloS one. 2022;17(2):1–16. doi: 10.1371/journal.pone.0263583 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61.Zenone M, Snyder J, Crooks VA. What are the informational pathways that shape people’s use of cannabidiol for medical purposes? Journal of Cannabis Research. 2021;3(1). doi: 10.1186/s42238-021-00069-x [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62.Pang RD, Dormanesh A, Hoang Y, Chu M, Allem J-P. Twitter Posts About Cannabis Use During Pregnancy and Postpartum:A Content Analysis. Substance Use & Misuse. 2021;56(7):1074–7. doi: 10.1080/10826084.2021.1906277 [DOI] [PubMed] [Google Scholar]
- 63.Rhidenour KB, Blackburn K, Barrett AK, Taylor S. Mediating Medical Marijuana: Exploring How Veterans Discuss Their Stigmatized Substance Use on Reddit. Health Communication. 2021:1–11. doi: 10.1080/10410236.2021.1886411 [DOI] [PubMed] [Google Scholar]
- 64.Smolev ET, Rolf L, Zhu E, Buday SK, Brody M, Brogan DM, et al. “Pill Pushers and CBD Oil”—A Thematic Analysis of Social Media Interactions About Pain After Traumatic Brachial Plexus Injury. Journal of Hand Surgery Global Online. 2021;3(1):36–40. doi: 10.1016/j.jhsg.2020.10.005 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 65.Zenone M, Snyder J, Caulfield T. Crowdfunding cannabidiol (CBD) for cancer: Hype and misinformation on gofundme. American Journal of Public Health. 2020;110:S294–S9. doi: 10.2105/AJPH.2020.305768 . [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66.Leas EC, Nobles AL, Caputi TL, Dredze M, Smith DM, Ayers JW. Trends in Internet Searches for Cannabidiol (CBD) in the United States. JAMA network open. 2019;2:e1913853. doi: 10.1001/jamanetworkopen.2019.13853 . [DOI] [PMC free article] [PubMed] [Google Scholar]
- 67.Shi S, Brant AR, Sabolch A, Pollom E. False News of a Cannabis Cancer Cure. Cureus. 2019;11(1):e3918–e. doi: 10.7759/cureus.3918 . [DOI] [PMC free article] [PubMed] [Google Scholar]
- 68.Saposnik FE, Huber JF. Trends in web searches about the causes and treatments of autism over the past 15 years: Exploratory infodemiology study. JMIR Pediatrics and Parenting. 2020;3. doi: 10.2196/20913 . [DOI] [PMC free article] [PubMed] [Google Scholar]
- 69.Daniulaityte R, Nahhas RW, Wijeratne S, Carlson RG, Lamy FR, Martins SS, et al. "Time for dabs": Analyzing Twitter data on marijuana concentrates across the U.S. Drug Alcohol Depend. 2015;155:307–11. doi: 10.1016/j.drugalcdep.2015.07.1199 . [DOI] [PMC free article] [PubMed] [Google Scholar]
- 70.Nasralah T, El-gayar OF, Wang Y. What Social Media Can Tell Us About Opioid Addicts: Twitter Data Case Analysis. 2019. [Google Scholar]
- 71.Mullins CF, Ffrench-O’Carroll R, Lane J, O’Connor T. Sharing the pain: An observational analysis of Twitter and pain in Ireland. Regional Anesthesia and Pain Medicine. 2020;45(8):597–602. doi: 10.1136/rapm-2020-101547 [DOI] [PubMed] [Google Scholar]
- 72.Dai H, Hao J. Mining social media data on marijuana use for Post Traumatic Stress Disorder. Computers in Human Behavior. 2017;70:282–90. doi: 10.1016/j.chb.2016.12.064 S0747563216308949. [DOI] [Google Scholar]
- 73.Turner J, Kantardzic M. Geo-social analytics based on spatio-temporal dynamics of marijuana-related tweets. ACM International Conference Proceeding Series. 2017;Part F1282:28–38. doi: 10.1145/3077584.3077588 [DOI] [Google Scholar]
- 74.Westmaas JL, McDonald BR, Portier KM. Topic modeling of smoking- and cessation-related posts to the American Cancer Society’s Cancer Survivor Network (CSN): Implications for cessation treatment for cancer survivors who smoke. Nicotine and Tobacco Research. 2017;19:952–9. doi: 10.1093/ntr/ntx064 . [DOI] [PubMed] [Google Scholar]
- 75.Yom-Tov E, Lev-Ran S. Adverse Reactions Associated With Cannabis Consumption as Evident From Search Engine Queries. JMIR Public Health and Surveillance. 2017;3:e77. doi: 10.2196/publichealth.8391 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 76.Glowacki EM, Glowacki JB, Wilcox GB. A text-mining analysis of the public’s reactions to the opioid crisis. Substance Abuse. 2018;39:129–33. doi: 10.1080/08897077.2017.1356795 . [DOI] [PubMed] [Google Scholar]
- 77.Meacham MC, Paul MJ, Ramo DE. Understanding emerging forms of cannabis use through an online cannabis community: An analysis of relative post volume and subjective highness ratings. Drug Alcohol Depend. 2018;188:364–9. doi: 10.1016/j.drugalcdep.2018.03.041 . [DOI] [PMC free article] [PubMed] [Google Scholar]
- 78.Allem J-P, Escobedo P, Dharmapuri L. Cannabis Surveillance With Twitter Data: Emerging Topics and Social Bots. American Journal of Public Health. 2020;110(3):357–62. doi: 10.2105/AJPH.2019.305461 . Language: English. Entry Date: 20200208. Revision Date: 20200303. Publication Type: Article. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 79.van Draanen J, Tao H, Gupta S, Liu S. Geographic Differences in Cannabis Conversations on Twitter: Infodemiology Study. JMIR Public Health and Surveillance. 2020;6:e18540. doi: 10.2196/18540 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 80.Soleymanpour M, Saderholm S, Kavuluru R. Therapeutic Claims in Cannabidiol (CBD) Marketing Messages on Twitter. 2021 IEEE International Conference on Bioinformatics and Biomedicine (BIBM), Bioinformatics and Biomedicine (BIBM), 2021 IEEE International Conference on: IEEE; 2021. p. 3083–8. [DOI] [PMC free article] [PubMed]
- 81.Allem J-P, Majmundar A, Dormanesh A, Donaldson SI. Identifying Health-Related Discussions of Cannabis Use on Twitter by Using a Medical Dictionary: Content Analysis of Tweets. JMIR formative research. Canada: JMIR Publications; 2022. p. e35027. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 82.Turner J, Kantardzic M, Vickers-Smith R. Infodemiological Examination of Personal and Commercial Tweets About Cannabidiol: Term and Sentiment Analysis. Journal of Medical Internet Research. 2022;23(12):e27307. doi: 10.2196/27307 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 83.Pérez-Pérez M, Pérez-Rodríguez G, Fdez-Riverola F, Lourenço A. Using twitter to understand the human bowel disease community: Exploratory analysis of key topics. Journal of Medical Internet Research. 2019;21. doi: 10.2196/12610 . [DOI] [PMC free article] [PubMed] [Google Scholar]
- 84.Tran T, Kavuluru R. Social media surveillance for perceived therapeutic effects of cannabidiol (CBD) products. International Journal of Drug Policy. 2020;77:102688. doi: 10.1016/j.drugpo.2020.102688 . [DOI] [PMC free article] [PubMed] [Google Scholar]
- 85.Janmohamed K, Soale AN, Forastiere L, Tang W, Sha Y, Demant J, et al. Intersection of the Web-Based Vaping Narrative with COVID-19: Topic Modeling Study. Journal of Medical Internet Research. 2020;22. doi: 10.2196/21743 . [DOI] [PMC free article] [PubMed] [Google Scholar]
- 86.Andersson M, Persson M, Kjellgren A. Psychoactive substances as a last resort-a qualitative study of self-treatment of migraine and cluster headaches. Harm Reduction Journal. 2017;14(1):1–10. doi: 10.1186/s12954-017-0186-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 87.Cavazos-Rehg PA, Krauss M, Fisher SL, Salyer P, Grucza RA, Bierut LJ. Twitter chatter about marijuana. Journal of Adolescent Health. 2015;56(2):139–45. doi: 10.1016/j.jadohealth.2014.10.270 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 88.Greiner C, Chatton A, Khazaal Y. Online self-help forums on cannabis: A content assessment. Patient Education and Counseling. 2017;100(10):1943–50. doi: 10.1016/j.pec.2017.06.001 [DOI] [PubMed] [Google Scholar]
- 89.Leas EC, Hendrickson EM, Nobles AL, Todd R, Smith DM, Dredze M, et al. Self-reported Cannabidiol (CBD) Use for Conditions With Proven Therapies. JAMA network open. 2020;3(10):e2020977–e. doi: 10.1001/jamanetworkopen.2020.20977 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 90.Merten JW, Gordon BT, King JL, Pappas C. Cannabidiol (CBD): Perspectives from Pinterest. Substance Use and Misuse. 2020;55(13):2213–20. doi: 10.1080/10826084.2020.1797808 [DOI] [PubMed] [Google Scholar]
- 91.Mitchell JT, Sweitzer MM, Tunno AM, Kollins SH, Joseph McClernon F. "I use weed for my ADHD": A qualitative analysis of online forum discussions on cannabis use and ADHD. PLoS ONE. 2016;11(5):1–13. doi: 10.1371/journal.pone.0156614 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 92.Pang RD, Dormanesh A, Hoang Y, Chu M, Allem JP. Twitter Posts About Cannabis Use During Pregnancy and Postpartum:A Content Analysis. Substance Use and Misuse. 2021;0(0):1–4. doi: 10.1080/10826084.2021.1906277 [DOI] [PubMed] [Google Scholar]
- 93.Song S, Cohen AJ, Lui H, Mmonu NA, Brody H, Patino G, et al. Use of GoFundMe® to crowdfund complementary and alternative medicine treatments for cancer. Journal of Cancer Research and Clinical Oncology. 2020;146(7):1857–65. doi: 10.1007/s00432-020-03191-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 94.Rhidenour KB, Blackburn K, Barrett AK, Taylor S. Mediating Medical Marijuana: Exploring How Veterans Discuss Their Stigmatized Substance Use on Reddit. Health Communication. 2021;00(00):1–11. doi: 10.1080/10410236.2021.1886411 [DOI] [PubMed] [Google Scholar]
- 95.Yue L, Chen W, Li X, Zuo W, Yin M. A survey of sentiment analysis in social media. Knowledge and Information Systems. 2019;60(2):617–63. doi: 10.1007/s10115-018-1236-4 [DOI] [Google Scholar]
- 96.Allem J-P, Majmundar A, Dormanesh A, Donaldson SI. Identifying Health-Related Discussions of Cannabis Use on Twitter by Using a Medical Dictionary: Content Analysis of Tweets. JMIR Form Res. 2022;6(2):e35027. doi: 10.2196/35027 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 97.Nasralah T, Spohn R. Social Media Text Mining Framework for Drug Abuse: An Opioid Crisis Case Analysis SOCIAL MEDIA TEXT MINING FRAMEWORK FOR DRUG ABUSE: AN OPIOID CRISIS CASE ANALYSIS A dissertation submitted to Dakota State University in partial fulfillment of the require. 2019. [Google Scholar]
- 98.van Draanen J, Tao H, Gupta S, Liu S. Geographic Differences in Cannabis Conversations on Twitter: Infodemiology Study. JMIR Public Health and Surveillance. 2020;6(4):e18540–e. doi: 10.2196/18540 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 99.Li M, Kakani N, li C, Park A. Understanding cannabis information on social media: Examining tweets from verified, regular, and suspended users 2020. 1–10 p. [Google Scholar]
- 100.Cavazos-Rehg PA, Krauss MJ, Sowles SJ, Murphy GM, Bierut LJ. Exposure to and Content of Marijuana Product Reviews. Prevention Science. 2018;19(2):127–37. doi: 10.1007/s11121-017-0818-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 101.Shi S, Brant AR, Sabolch A, Pollom E. False News of a Cannabis Cancer Cure. Cureus. 2019;11(1):1–11. doi: 10.7759/cureus.3918 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 102.Pérez-Pérez M, Pérez-Rodríguez G, Fdez-Riverola F, Lourenço A. Using twitter to understand the human bowel disease community: Exploratory analysis of key topics. Journal of Medical Internet Research. 2019;21(8). doi: 10.2196/12610 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 103.Glowacki EM, Glowacki JB, Wilcox GB. A text-mining analysis of the public’s reactions to the opioid crisis. Substance Abuse. 2018;39(2):129–33. doi: 10.1080/08897077.2017.1356795 [DOI] [PubMed] [Google Scholar]
- 104.Meacham MC, Nobles AL, Tompkins DA, Thrul J. "I got a bunch of weed to help me through the withdrawals": Naturalistic cannabis use reported in online opioid and opioid recovery community discussion forums. PloS one. 2022;17(2):e0263583. Epub 20220208. doi: 10.1371/journal.pone.0263583 ; PubMed Central PMCID: PMC8824349. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 105.Gonzalez-Estrada A, Cuervo-Pardo L, Ghosh B, Smith M, Pazheri F, Zell K, et al. Popular on YouTube: A critical appraisal of the educational quality of information regarding asthma. Allergy and Asthma Proceedings. 2015;36(6):e121–e6. doi: 10.2500/aap.2015.36.3890 [DOI] [PubMed] [Google Scholar]
- 106.Westmaas JL, McDonald BR, Portier KM. Topic modeling of smoking- and cessation-related posts to the American Cancer Society’s Cancer Survivor Network (CSN): Implications for cessation treatment for cancer survivors who smoke. Nicotine and Tobacco Research. 2017;19(8):952–9. doi: 10.1093/ntr/ntx064 [DOI] [PubMed] [Google Scholar]
- 107.Saposnik FE, Huber JF. Trends in web searches about the causes and treatments of autism over the past 15 years: Exploratory infodemiology study. JMIR Pediatrics and Parenting. 2020;3(2). doi: 10.2196/20913 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 108.Leas EC, Nobles AL, Caputi TL, Dredze M, Smith DM, Ayers JW. Trends in Internet Searches for Cannabidiol (CBD) in the United States. JAMA network open. 2019;2(10):e1913853–e. doi: 10.1001/jamanetworkopen.2019.13853 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 109.Tran T, Kavuluru R. Social media surveillance for perceived therapeutic effects of cannabidiol (CBD) products. International Journal of Drug Policy. 2020;77:102688–. doi: 10.1016/j.drugpo.2020.102688 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 110.Kazemi DM, Borsari B, Levine MJ, Dooley B. Systematic review of surveillance by social media platforms for illicit drug use. Journal of Public Health (United Kingdom). 2017;39(4):763–76. doi: 10.1093/pubmed/fdx020 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 111.Grinspoon L, Bakalar JB. Marihuana, the forbidden medicine: Yale University Press; 1997. [Google Scholar]
- 112.Belackova V, Ritter A, Shanahan M, Chalmers J, Hughes C, Barratt M, et al. Medicinal cannabis in Australia–Framing the regulatory options. Sydney: Drug Policy Modelling Program. 2015. [Google Scholar]
- 113.Lardon J, Bellet F, Aboukhamis R, Asfari H, Jaulent M, Beyens M, et al. Evaluating Twitter as a complementary data source for pharmacovigilance Expert Opinion on Drug Safety. 2018;17(8):763–74. [DOI] [PubMed] [Google Scholar]
- 114.Bode L, Davis-Kean P, Singh L, Berger-Wolf T, Budak C, Chi G, et al. Study designs for quantitative social science research using social media. 2020. [Google Scholar]
- 115.Chancellor S, De Choudhury M. Methods in predictive techniques for mental health status on social media: a critical review. npj Digital Medicine. 2020;3(1). doi: 10.1038/s41746-020-0233-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 116.Abbasi A, Sarker A, Ginn R, Smit K, Oconnor K, Abbasi A. Social Media Analytics for Smart Health. [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
(DOCX)
(DOCX)
(DOCX)
(DOCX)
(DOCX)
(XLSX)
Data Availability Statement
All relevant data are within the manuscript and its Supporting Information files.

